Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Vet Med Sci ; 9(1): 53-58, 2023 Jan.
Article in English | MEDLINE | ID: mdl-36571805

ABSTRACT

A 5-year-old spayed female American Staffordshire was referred for weakness, reluctance to move and distension of the abdomen. Three weeks before, the dog underwent surgery for excision of a nodular mass suspected to be a non-epitheliotropic cutaneous T-cell lymphoma (NE-CTCL). Computed tomography revealed heterogeneous enhancing mesenteric masses and nodular lesions of soft tissue density, and infiltration of the abdominal muscular wall. Moreover, a pattern of diffuse muscle nodules in the skeletal muscles was visible, with lesions showing homogenous, heterogeneous or ring enhancement. Necrosis was histologically observed and these lesions were infiltrated by CD3-positive and CD20-, CD79a- and Iba1-negative neoplastic lymphocytes. On the basis of the immunopathological features metastatic NE-CTCL was suspected. Skeletal muscle metastasis has been rarely reported in small animals and this case report further confirms that this possibility should be considered in dogs with lymphoma.


Subject(s)
Dog Diseases , Lymphoma, T-Cell , Lymphoma , Skin Neoplasms , Dogs , Female , Animals , Skin Neoplasms/veterinary , Lymphoma, T-Cell/veterinary , Lymphoma, T-Cell/pathology , Lymphoma/veterinary , Muscle, Skeletal/pathology , Dog Diseases/diagnostic imaging , Dog Diseases/surgery , Dog Diseases/pathology
2.
Vet J ; 197(3): 776-81, 2013 Sep.
Article in English | MEDLINE | ID: mdl-23735731

ABSTRACT

The aims of this study were to assess the prognostic significance of bone marrow (BM) infiltration in canine large B cell lymphoma (LBCL) and to establish cut-off values for designating the BM as infiltrated by lymphoid blasts. The degree of BM infiltration by large CD21 positive cells in dogs with LBCL was assessed by flow cytometry (FC) and related to time to progression (TTP) and lymphoma-specific survival (LSS). Forty-six dogs were prospectively enrolled, staged and treated with a dose-intense chemotherapeutic protocol. BM infiltration was directly correlated with peripheral blood infiltration (P=0.001), high lactate dehydrogenase activity (P=0.0024) and substage b disease (P<0.001). In the univariate analysis, there was a significant association between BM infiltration diagnosed by FC and both TTP (P=0.001) and LSS (P<0.001). Substage was the only factor associated with TTP in the multivariate analysis (P=0.002), whereas substage (P<0.001) and anaemia (P=0.008) were associated with LSS. A cut-off of 3% BM infiltration had the strongest prognostic value, since it discriminated between dogs with a poorer prognosis (median TTP 69 days; median LSS 155 days) and dogs with a better prognosis (median TTP 149 days; median LSS 322 days). BM analysis is an essential step in the staging of LBCL. The presence of BM infiltration by FC at diagnosis is a negative prognostic indicator in canine LBCL.


Subject(s)
Bone Marrow Diseases/veterinary , Dog Diseases/pathology , Flow Cytometry/veterinary , Lymphoma, B-Cell/veterinary , Animals , Bone Marrow Diseases/pathology , Dog Diseases/diagnosis , Dogs , Female , Lymphoma, B-Cell/pathology , Male , Prognosis
SELECTION OF CITATIONS
SEARCH DETAIL
...